AI assistant
Sending…
Ensysce Biosciences, Inc. — Director's Dealing 2017
Dec 6, 2017
35337_dirs_2017-12-05_f1c60103-d290-4482-870f-b874fe7a4290.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Leisure Acquisition Corp. (LACQ)
CIK: 0001716947
Period of Report: 2017-12-05
Reporting Person: Peng George (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-05 | Common Stock | J | 733 | — | Disposed | 100265 | Direct |
Footnotes
F1: As contemplated by the securities subscription agreement between the reporting person and the Company, 733 shares held by Mr. Peng were forfeited upon consummation of the Company's initial public offering for no consideration.
F2: Includes an aggregate of 13,251 shares held by Mr. Peng that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not fully exercised.
More from Ensysce Biosciences, Inc.
Share Issue/Capital Change
2026
Jun 4
Delisting Announcement
2026
May 22
Interim / Quarterly Report
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
Mar 23
Delisting Announcement
2026
Feb 27
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 8
Proxy Solicitation & Information Statement
2025
Dec 16
Regulatory Filings
2025
Dec 12
Capital/Financing Update
2025
Dec 2